Silver Book Fact

Mortality rate from hospital-acquired pneumonia

The mortality rate for hospital-acquired pneumonia ranges from 38% to more than 70%.

Laessig K. End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration perspective. Clin Infect Dis. 2010; 181(6): 1897-905. http://cid.oxfordjournals.org/content/51/Supplement_1/S117.full

Reference

Title
End Points in Hospital-Acquired Pneumonia and/or Ventilator-Associated Pneumonia Clinical Trials: Food and Drug Administration perspective
Publication
Clin Infect Dis
Publication Date
2010
Authors
Laessig K
Volume & Issue
Volume 181, Issue 6
Pages
1897-905
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Related Facts

  • Drug resistant infections cost $16.6 – $26 billion to US healthcare system annually
    Drug-resistant infections cost the U.S. healthcare system between $16.6 and $26 billion in extra costs each year.  
  • Infection and related sepsis leading cause of death in noncardiac-ICUs
    Infection and related sepsis/septicemia are the leading cause of death in noncardiac-ICUs, accounting for as many as 60% of deaths.  
  • Primary sources of HAIs
    Around 2/3 of all HAIs are central-line associated bloodstream infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia. Surgical site infections and Clostridium difficile (C. difficile) are also common HAIs.  
  • Majority of C. diff deaths in ages 65+
    More than 90% of deaths from C. difficile infectious occur in people ages 65 and older.  
  • Drug-resistant MRSA expensive to treat
    As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.